Vivos Primarna funkcija: Sistem za oftalmološku hirurgiju od Olcayto Guelec and David Geuder

Dizajn Vivos Primarna funkcija: Sistem za oftalmološku hirurgiju od dizajnera Olcayto Guelec and David Geuder je visoko cijenjeni dobitnik prestižne nagrade 2026 Zlatna nagrada A' Design Award u kategoriji Dizajn Medicinskih Uređaja i Medicinske Opreme.

ZlatoMedicinski Proizvod· 2026

Vivos Primarna funkcija: Sistem za oftalmološku hirurgiju

autor Olcayto Guelec and David Geuder

Klijent: Geuder AG

Dobitnik nagrade Zlatna nagrada A' Design Award u kategoriji Medicinski Proizvod

56,783

Verificirani dobitnik nagrade

Verificirajte status nagrade za #182492

Pogledajte na A' Design Award Saopštenje za medije Značka nagrade

Boje

Dizajn

O dizajnu Vivos Primarna funkcija: Sistem za oftalmološku hirurgiju

Tekst knjige: Vivos redefiniše hiruršku radnu stanicu kao platformu koja se razvija zajedno sa kliničkim ambicijama. Tri konfiguracije, Core, Nova i Nova+, proširuju mogućnosti bez zamjene sistema, jedina arhitektura nadogradnje ove vrste u oftalmološkoj hirurgiji. Jedinstveni interfejs, potvrđen sa 91,7 posto zadovoljstva prilikom prve upotrebe bez prethodne obuke, odražava dizajn izgrađen oko hirurga, a ne oko procedure. Osvijetljeni priključci za instrumente, profinjeni materijali i suzdržana obrada daju uređaju smiren i samouvjeren prisustvo, oslobođeno vizuelne buke tipične za ovu kategoriju.

Priznanje

O nagradi Zlatna nagrada A' Design Award

Vivos Primarna funkcija: Sistem za oftalmološku hirurgiju je pobjednik Zlatne nagrade A' Design Award, iznimno prestižnog priznanja koje se dodjeljuje prvorazrednim, čudesnim i izvanrednim dizajnima. Zlatni pobjednici iznimno su inovativne, vrlo vizionarske i blistavo zasljepljujuće kreacije koje odražavaju genij, mudrost i umijeće svojih dizajnera. Očekuje se da Vivos Primarna funkcija: Sistem za oftalmološku hirurgiju bude vrlo hvaljen, trendovski i monumentalan izum koji pruža bezprecedentnu vrijednost. Ovaj dizajn koji je osvojio Zlatnu nagradu A' Design Award spektakularan je, cijenjen projekt koji izuzetno koristi i pomjera granice umjetnosti, nauke, dizajna i tehnologije. Vivos Primarna funkcija: Sistem za oftalmološku hirurgiju stvara snažne osjećaje želje, budi strast, podstiče kreativnost i fascinira nas.

Iza dizajna

Press komplet

Zasluge, članovi tima i tehnički detalji koje je dostavio dizajner.

Jedinstvena svojstva: Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Dimenzije i pakovanje: Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Oznake: Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Tehnologija proizvodnje: Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Dizajnerski izazov: The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Istraživanje: Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Inspiracija: Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Trajanje projekta: The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Tok rada: Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Članovi tima: Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
Autorstvo slika: Photography Geuder AG, 2026